NOT KNOWN FACTS ABOUT 4F-MPH

It is just a nootropic drug invented in 1996 by a workforce Operating for Merck, Sharp and Dohme, which was the initial compound designed which acts being a subtype-selective inverse agonist for the α5 subtype on the benzodiazepine binding site on the GABAA receptor.4F-MPH is thought to act principally as being a dopamine and norepinephrine reupta